BR100 Decreased By (-0.64%)
BR30 Decreased By (-0.49%)
KSE100 Decreased By (-0.49%)
KSE30 Decreased By (-0.6%)
AGHA 7.69 Decreased By ▼ -0.12 (-1.54%)
BECO 5.15 Decreased By ▼ -0.06 (-1.15%)
BML 57.96 Increased By ▲ 0.46 (0.8%)
BOP 34.08 Increased By ▲ 0.05 (0.15%)
CNERGY 10.08 Increased By ▲ 0.12 (1.2%)
CSIL 5.30 Decreased By ▼ -0.01 (-0.19%)
FCCL 53.89 Decreased By ▼ -0.81 (-1.48%)
FFL 16.60 Decreased By ▼ -0.09 (-0.54%)
FNEL 1.23 No Change ▼ 0.00 (0%)
KEL 7.29 Decreased By ▼ -0.11 (-1.49%)
KOSM 5.79 Increased By ▲ 0.02 (0.35%)
LOTCHEM 29.25 Decreased By ▼ -0.07 (-0.24%)
MLCF 92.40 Decreased By ▼ -1.96 (-2.08%)
NBP 201.50 Decreased By ▼ -1.55 (-0.76%)
NCPL 57.00 No Change ▼ 0.00 (0%)
NPL 67.38 Decreased By ▼ -0.32 (-0.47%)
OGDC 315.49 Decreased By ▼ -0.35 (-0.11%)
PACE 10.56 Decreased By ▼ -0.08 (-0.75%)
PAEL 42.66 Decreased By ▼ -0.54 (-1.25%)
PIBTL 16.60 Decreased By ▼ -0.14 (-0.84%)
PPL 218.82 Decreased By ▼ -0.96 (-0.44%)
PRL 51.40 Increased By ▲ 2.21 (4.49%)
PTC 70.20 Decreased By ▼ -0.33 (-0.47%)
SSGC 27.46 Decreased By ▼ -0.79 (-2.8%)
TBL 9.78 Decreased By ▼ -0.08 (-0.81%)
TELE 8.74 Decreased By ▼ -0.05 (-0.57%)
TPL 18.31 Increased By ▲ 0.07 (0.38%)
TPLP 13.50 Increased By ▲ 0.23 (1.73%)
TREET 22.50 Decreased By ▼ -0.22 (-0.97%)
TRG 60.05 Decreased By ▼ -0.09 (-0.15%)
Pakistan

China's CanSinoBIO COVID-19 vaccine approved for emergency use in Pakistan

  • The approval was granted by the authority’s registration board on Friday.
  • Pakistan is the second country to approve use of China’s vaccine after Mexico.
Published Updated

The Drug Regulatory Authority of Pakistan (DRAP) has approved the emergency use of Chinese coronavirus (COVID-19) vaccine from CanSino Biologics.

As per details, the approval was granted by the authority’s registration board on Friday.

A request for the approval of the drug for emergency use was submitted to DRAP's registration board by AJM Pharma (Pvt) Limited, the report said.

The decision to approve it was taken during the third meeting of the authority's registration board.

Pakistan is the second country to approve use of China’s vaccine after Mexico.

Clinical trials for CanSinoBIO's vaccine were already going on in several countries, including Pakistan.

Comments

Comments are closed for this article.